Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • active pharmaceutical...

    Tag: active pharmaceutical ingredients

    You Searched For "active pharmaceutical ingredients"
    Indias dependence on pharma imports from China: Minister informs parliament

    India's dependence on pharma imports from China: Minister informs parliament

    Medical Dialogues Bureau17 March 2020 3:50 PM IST
    Delhi: Through a written reply in the Lok Sabha Shri. D.V. Sadananda Gowda, Minister for Chemicals & fertilizers informed the parliament about the...
    Coronavirus Scare: Minister apprises parliament about the availability of drugs and shortages

    Coronavirus Scare: Minister apprises parliament about the availability of drugs and shortages

    Medical Dialogues Bureau14 March 2020 3:03 PM IST
    Delhi: Through a written reply in the Rajya Sabha Shri. D.V. Sadananda Gowda, Minister for Chemicals & fertilizers informed the parliament that...
    Ensure that there is no hoarding, blackmarketing of medicines: NPPA chief tells states on Covid-19 outbreak

    Ensure that there is no hoarding, blackmarketing of medicines: NPPA chief tells states on Covid-19 outbreak

    Medical Dialogues Bureau27 Feb 2020 3:00 PM IST
    State Governments and UTs are requested to closely monitor the production and availability of APIs and their formulations to prevent black marketing...
    Sanofi plans to create standalone company dedicated to making APIs

    Sanofi plans to create standalone company dedicated to making APIs

    Medical Dialogues Bureau26 Feb 2020 3:37 PM IST
    PARIS : Sanofi plans to create a standalone company dedicated to making active pharmaceutical ingredients (API), components that are biologically...
    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

    Farhat Nasim14 Oct 2019 1:36 PM IST
    While two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Medical Dialogues Bureau11 Oct 2019 10:00 AM IST
    "The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
    CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers

    CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers

    Meghna A Singhania27 Sept 2019 12:19 PM IST
    New Delhi : Taking into consideration, the proposal on measures need to be taken to address the issue of repacking of Active Pharmaceutical...
    Biocon inks license, supply pact with CMS for 3 generic formulations

    Biocon inks license, supply pact with CMS for 3 generic formulations

    Medical Dialogues Bureau13 Sept 2019 2:45 PM IST
    Under the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products and China Medical System...
    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    Medical Dialogues Bureau29 Aug 2019 4:10 PM IST
    New Delhi: The Drugs Technical Advisory Board (DTAB) has recently recommended for amendment of the Drugs and Cosmetics Rules, 1945 regarding...
    CDSCO preparing list of dual-use APIs imported from unregistered firms

    CDSCO preparing list of dual-use APIs imported from unregistered firms

    Medical Dialogues Bureau26 Aug 2019 2:23 PM IST
    "The Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and the Department of Pharmaceuticals want to put a stop to the...
    USFDA completes inspection at Laurus Labs

    USFDA completes inspection at Laurus Labs' AP unit

    Medical Dialogues Bureau19 July 2019 10:02 AM IST
    Mumbai: Laurus labs recently announced that they have completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam,...
    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Medical Dialogues Bureau8 July 2019 1:32 PM IST
    As part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok